The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours and normal tissues. In prostate cancer it is estimated that annually about 300 patients and in gynaecological cancer about 50 patients, are candidates for proton beam therapy. Owing to major uncertainties, it has not been possible to give an estimate of the number of potential patients with urinary bladder cancer.
Johansson
Bengt
B
Department of General Oncology, Orebro University Hospital, Orebro, Sweden. bengt.johansson@orebroll.se
Ridderheim
Mona
M
Glimelius
Bengt
B
D003362:Cost-Benefit Analysis; D005260:Female; D005833:Genital Neoplasms, Female / Q000191:economics / Q000532:radiotherapy*; D017048:Health Care Costs / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000191:economics / Q000532:radiotherapy*; D061766:Proton Therapy; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D013548:Sweden; D001749:Urinary Bladder Neoplasms / Q000191:economics / Q000532:radiotherapy*; D014571:Urologic Neoplasms / Q000191:economics / Q000532:radiotherapy*; D011522:Protons
D011522:Protons